TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive NCI to Suggest Changes In Cooperative Group Terms of Award At Chairman’s Meeting Next Week November 18, 1988
TCL Archive Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia July 26, 2002